ARCHIVES

In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End

This article is from The Cancer Letter archive.

Vol. 25 No. 45 | November 26, 1999

Download PDF Visit The Full Archive

Related Articles

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

Diane Fink Accepts VP Job With ACS

April 3, 1981

Preclinical Models: NCI Advisors OK Plan For Mouse Models Consortium

March 13, 1998

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996

Collins Sworn In As NIH Director

September 4, 2009

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993